UPDATE 1-Evonik beats market expectations with Q1 core profit [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
first-quarter core profit above market expectations, citing higher sales volumes in its Specialty Additives and Nutrition & Care divisions. The company posted adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) of 522 million euros ($554.05 million) in the quarter, beating by 16% the forecast of analysts in a Vara Research poll of 450.4 million euros. Evonik's chemicals are used in products from cars to animal feed, as well as in Pfizer and BioNTech's COVID vaccine. The specialty chemicals maker also published Q1 sales of 3.8 billion euros, slightly below analysts' expectations of 3.9 billion, as lower raw material costs caused sales prices to decline. Evonik confirmed its outlook for the current year released in March, when the company also announced plans to cut around 2,000 jobs worldwide by 2026. Final results will be published as planned on May 8, the company added. ($1 = 0.9422 euros) (Reporting by Anastasiia Kozlova and Amir Orusov,
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings [Yahoo! Finance]Yahoo! Finance
- Biodexa gains license for polyposis asset as stock more than doubles [Yahoo! Finance]Yahoo! Finance
- Carboprost Tromethamine Market to Gain 2.96 Billion, by 2033 with 4% CAGR: States The Brainy Insights [Yahoo! Finance]Yahoo! Finance
- A Better Concept For mRNA Vaccines: Self-Amplification [Forbes]Forbes
- Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 1/30/24 - Beat
PFE
Sec Filings
- 4/29/24 - Form 8-K
- 4/26/24 - Form 4
- 4/26/24 - Form 4
- PFE's page on the SEC website